117 related articles for article (PubMed ID: 22718120)
21. Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells.
Burgeiro A; Gajate C; Dakir el H; Villa-Pulgarín JA; Oliveira PJ; Mollinedo F
Anticancer Drugs; 2011 Jul; 22(6):507-18. PubMed ID: 21527846
[TBL] [Abstract][Full Text] [Related]
22. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
[TBL] [Abstract][Full Text] [Related]
23. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
[TBL] [Abstract][Full Text] [Related]
24. Regulation of fas/fas ligand-mediated apoptosis by nuclear factor of activated T cells in megakaryocytes.
Arabanian LS; Kujawski S; Habermann I; Ehninger G; Kiani A
Br J Haematol; 2012 Feb; 156(4):523-34. PubMed ID: 22171718
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis.
Zhao Y; Zhang Y; Yang Z; Li A; Dong J
Biochem Biophys Res Commun; 2008 Jun; 370(3):509-13. PubMed ID: 18402768
[TBL] [Abstract][Full Text] [Related]
26. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
Wang AX; Qi XY
IUBMB Life; 2013 Sep; 65(9):748-58. PubMed ID: 23893853
[TBL] [Abstract][Full Text] [Related]
27. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
28. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
Yeh AH; Bohula EA; Macaulay VM
Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
[TBL] [Abstract][Full Text] [Related]
29. A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status.
Zipser MC; Eichhoff OM; Widmer DS; Schlegel NC; Schoenewolf NL; Stuart D; Liu W; Gardner H; Smith PD; Nuciforo P; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Apr; 24(2):326-33. PubMed ID: 21176117
[TBL] [Abstract][Full Text] [Related]
30. NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.
Flockhart RJ; Armstrong JL; Reynolds NJ; Lovat PE
Br J Cancer; 2009 Oct; 101(8):1448-55. PubMed ID: 19724275
[TBL] [Abstract][Full Text] [Related]
31. Sensitization of melanoma cells for TRAIL-induced apoptosis by activation of mitochondrial pathways via Bax.
Quast SA; Berger A; Plötz M; Eberle J
Eur J Cell Biol; 2014; 93(1-2):42-8. PubMed ID: 24361324
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma.
Nakamura A; Arita T; Tsuchiya S; Donelan J; Chouitar J; Carideo E; Galvin K; Okaniwa M; Ishikawa T; Yoshida S
Cancer Res; 2013 Dec; 73(23):7043-55. PubMed ID: 24121489
[TBL] [Abstract][Full Text] [Related]
33. Antiapoptotic role of endogenous nitric oxide in human melanoma cells.
Salvucci O; Carsana M; Bersani I; Tragni G; Anichini A
Cancer Res; 2001 Jan; 61(1):318-26. PubMed ID: 11196180
[TBL] [Abstract][Full Text] [Related]
34. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
[TBL] [Abstract][Full Text] [Related]
35. Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Ding W; Tong Y; Zhang X; Pan M; Chen S
Sci Rep; 2016 Jan; 6():19793. PubMed ID: 26795951
[TBL] [Abstract][Full Text] [Related]
36. Targeting x-linked inhibitor of apoptosis protein for melanoma therapy: the need for more homogeneous samples and the importance of cell lines.
Kwatra SG
J Invest Dermatol; 2011 Mar; 131(3):797. PubMed ID: 21068753
[No Abstract] [Full Text] [Related]
37. On the TRAIL to overcome BRAF-inhibitor resistance.
Geserick P; Herlyn M; Leverkus M
J Invest Dermatol; 2014 Feb; 134(2):315-318. PubMed ID: 24424456
[TBL] [Abstract][Full Text] [Related]
38. Opposing roles for calcineurin and ATF3 in squamous skin cancer.
Wu X; Nguyen BC; Dziunycz P; Chang S; Brooks Y; Lefort K; Hofbauer GF; Dotto GP
Nature; 2010 May; 465(7296):368-72. PubMed ID: 20485437
[TBL] [Abstract][Full Text] [Related]
39. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure.
Bourajjaj M; Armand AS; da Costa Martins PA; Weijts B; van der Nagel R; Heeneman S; Wehrens XH; De Windt LJ
J Biol Chem; 2008 Aug; 283(32):22295-303. PubMed ID: 18477567
[TBL] [Abstract][Full Text] [Related]
40. Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases.
Raghavendra PB; Sreenivasan Y; Ramesh GT; Manna SK
Apoptosis; 2007 Feb; 12(2):307-18. PubMed ID: 17203245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
